On April 28, 2023 2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, will report its first quarter 2023 financial results on Wednesday, May 3, 2023 (Press release, 2seventy bio, APR 28, 2023, View Source [SID1234630664]). 2seventy bio will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Participants can access the conference call live via webcast which will be available on the investor page of the company’s website at View Source Participants who wish to ask a question may register here at https://register.vevent.com/register/BI458c3098c2a64310b49e967327a906e7 to receive dial-in numbers and a unique pin to join the call. It is recommended that participants join 10 minutes prior to the event’s start. A replay of the call will be available on the 2seventy bio website following the completion of the call.